Top Buy
| Security | Buy ▲ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Canopy Growth Corp | 4 | 0 | 0 | 0 | €0.47 | €1.75 | 273.134% |
| Sanofi S.A. | 4 | 0 | 0 | 0 | €91.03 | €99.50 | 9.305% |
| AC Immune Ltd | 4 | 0 | 0 | 0 | €2.21 | €12.27 | 455.367% |
| Anika Therapeutics | 4 | 0 | 0 | 0 | €24.60 | €26.58 | 8.054% |
| Eledon Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €2.10 | €12.09 | 475.686% |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €182.50 | -1.351% |
| GSK plc ADR | 4 | 0 | 0 | 0 | €40.60 | - | - |
| Chimerix Inc. | 4 | 1 | 0 | 0 | €0.89 | €5.51 | 520.315% |
| Xeris Biopharma Holdings Inc. | 4 | 0 | 0 | 0 | €1.75 | €4.39 | 150.645% |
| Kala Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €6.09 | €19.86 | 226.189% |
| Vanda Pharmaceuticals | 4 | 0 | 1 | 0 | €4.52 | €5.00 | 10.619% |
| Actinium Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €8.28 | €8.50 | 2.719% |
| Apellis Pharmaceuticals | 4 | 0 | 0 | 0 | €44.27 | €70.00 | 58.121% |
| Phibro Animal Health Corp. A | 4 | 1 | 0 | 0 | €15.10 | €13.89 | -8.005% |
| Galmed Pharmaceuticals Ltd. | 4 | 0 | 0 | 0 | €0.36 | €61.56 | 16999.750% |
| Fate Therapeutics Inc. | 5 | 2 | 2 | 1 | €3.78 | €8.27 | 118.625% |
| Agios Pharmaceuticals Inc. | 5 | 0 | 2 | 0 | €30.60 | €38.99 | 27.414% |
| Syros Pharmaceuticals Inc. | 5 | 1 | 1 | 1 | €4.78 | €12.80 | 167.814% |
| Purple Biotech Ltd. ADR | 5 | 0 | 1 | 0 | €0.48 | €9.21 | 1802.273% |
| Dr. Reddy's Laboratories Ltd. ADR | 5 | 1 | 1 | 0 | €69.50 | €73.92 | 6.360% |
| Hutchison China MediTech Ltd ADR | 5 | 0 | 0 | 0 | €18.30 | €45.10 | 146.421% |
| Enanta Pharmaceuticals Inc. | 5 | 4 | 0 | 1 | €12.70 | €26.92 | 111.996% |
| Glycomimetics Inc. | 5 | 0 | 0 | 0 | €1.71 | €7.35 | 330.926% |
| Immunogen Inc. | 5 | 0 | 1 | 0 | €28.97 | - | - |
| SCYNEXIS Inc. | 5 | 0 | 0 | 0 | €1.66 | €3.00 | 80.723% |